STACY A HEIMBURGER

Allopathic & Osteopathic Physicians|Internal Medicine NEW ORLEANS, LA NPI 1598922007

General Payments — all program years on this page

$1,422.36

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 92
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $363.45 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $363.4521

By paying entity

Latest program year (PY2021) · sorted by reported total.

Paying entityAmountRecords
PFIZER INC. $257.5515
Relypsa, Inc. $39.022
Janssen Pharmaceuticals, Inc $31.182
E.R. Squibb & Sons, L.L.C. $23.131
Acerta Pharma LLC $12.571

By program year

Program yearAmountRecords
2018 $287.2321
2019 $396.8931
2020 $374.7919
2021 $363.4521

Records — PY2021 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
783614279 E.R. Squibb & Sons, L.L.C. $23.13 03/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788460055 Janssen Pharmaceuticals, Inc $11.65 05/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788460059 Janssen Pharmaceuticals, Inc $19.53 12/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
816115351 Vifor Pharma, Inc. $17.07 06/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
816124647 Vifor Pharma, Inc. $21.95 08/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829961929 AstraZeneca Pharmaceuticals LP $12.57 08/28/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832544067 PFIZER INC. $19.98 03/10/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832547535 PFIZER INC. $23.43 04/06/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832574911 PFIZER INC. $8.60 07/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832576273 PFIZER INC. $21.23 01/29/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832626051 PFIZER INC. $19.04 01/06/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832659413 PFIZER INC. $26.09 05/11/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832660471 PFIZER INC. $22.56 04/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832696004 PFIZER INC. $20.22 02/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832701825 PFIZER INC. $20.33 03/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833263289 PFIZER INC. $8.83 10/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833263293 PFIZER INC. $9.90 09/29/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833263297 PFIZER INC. $15.69 09/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833263829 PFIZER INC. $14.85 12/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833263833 PFIZER INC. $12.60 11/10/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833263837 PFIZER INC. $14.20 11/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.